Board votes to change company name from First Horizon Pharmaceutical to Sciele Pharma

By Lisa Kerner

Charlotte, N.C., June 15 - First Horizon Pharmaceutical Corp. voted to approve the company's name change to Sciele Pharma, Inc.

As a result, the company's stock will begin trading on the Nasdaq Stock Market under the new symbol SCRX effective June 19.

"As we have grown and evolved into a more fully integrated pharmaceutical company, we felt this was an appropriate time to improve the company's branding to better reflect our organization," chief executive officer and president Patrick Fourteau said in a company news release.

The new name, pronounced SCI-el, more accurately reflects the company's focus on acquiring, licensing, developing and marketing branded prescription pharmaceuticals, officials said.

Sciele Pharma, located in Alpharetta, Ga., specializes cardiovascular and metabolic disorders and women's health.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.